Participant flow18

How many started, completed or left each group, period by period.

1 to 18 of 18

Period	Milestone	Group	Participants
Overall Study	STARTED	Study A: Placebo	68
Overall Study	STARTED	Study A: Dupilumab	70
Overall Study	STARTED	Study B: Placebo	54
Overall Study	STARTED	Study B: Dupilumab	54
Overall Study	STARTED	Study C: Placebo	77
Overall Study	STARTED	Study C: Dupilumab	74
Overall Study	COMPLETED	Study A: Placebo	55
Overall Study	COMPLETED	Study A: Dupilumab	63
Overall Study	COMPLETED	Study B: Placebo	47
Overall Study	COMPLETED	Study B: Dupilumab	49
Overall Study	COMPLETED	Study C: Placebo	67
Overall Study	COMPLETED	Study C: Dupilumab	66
Overall Study	NOT COMPLETED	Study A: Placebo	13
Overall Study	NOT COMPLETED	Study A: Dupilumab	7
Overall Study	NOT COMPLETED	Study B: Placebo	7
Overall Study	NOT COMPLETED	Study B: Dupilumab	5
Overall Study	NOT COMPLETED	Study C: Placebo	10
Overall Study	NOT COMPLETED	Study C: Dupilumab	8

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04180488/flow